Applied Finance Capital Management LLC Cuts Position in Danaher Corporation $DHR

Applied Finance Capital Management LLC decreased its holdings in Danaher Corporation (NYSE:DHR) by 7.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 51,954 shares of the conglomerate’s stock after selling 4,465 shares during the period. Applied Finance Capital Management LLC’s holdings in Danaher were worth $11,893,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Sivia Capital Partners LLC boosted its holdings in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares during the last quarter. First Trust Advisors LP grew its stake in Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after purchasing an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC grew its stake in Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC grew its stake in Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC increased its stake in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after buying an additional 325 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

DHR stock opened at $161.95 on Friday. The company has a market capitalization of $114.62 billion, a P/E ratio of 31.32, a PEG ratio of 2.20 and a beta of 0.81. The company has a 50-day simple moving average of $186.30 and a 200 day simple moving average of $210.38. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the business earned $1.88 earnings per share. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. Sell-side analysts predict that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 1.0%. Danaher’s payout ratio is 30.95%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DHR. Royal Bank Of Canada began coverage on shares of Danaher in a research note on Thursday. They issued an “outperform” rating and a $200.00 price target for the company. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Finally, UBS Group dropped their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $238.65.

Insider Buying and Selling

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 10.80% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.